共 19 条
- [1] Detection of preclinical Parkinson′s disease at risk family members with use of[123I]-β-CITand SPECT:an exploratory study. Maraganore DM,O′Connor MK,Bower JH,et al. Mayo Clinic Proceedings . 1999
- [2] [99mTc]TRODAT-1:a novel technetium-99mcomplex as a dopamine transporter i maging agent. Kung MP,Stevenson DA,Plossl K et al. European Journal of Nuclear Medicine . 1997
- [3] I maging of dopamine transporters with99mTc-TRODAT-1and single photon emission computed to-mography. Bao SY,Wu JC,Luo WF,et al. J Neuroi maging Neurol I mag . 2000
- [4] Does along preclinical period occur in Parkinson′s disease. Koller WC,Langston J W,Hubble JP,et al. Neurology . 1991
- [5] Initial human PET imagingstudies with the dopamine transporter ligand18F-FEC-NT. Davis MR,Votaw JR,Bremner JD,et al. The Journal of Nuclear Medicine . 2003
- [6] Imaging of dopamine transporters with iodine-123 β- CIT and SPECT in Parkinson’s disease. Asenbaum S,Brucke T,Pirker W,et al. The Journal of Nuclear Medicine . 1997
- [7] Synthesis and characterization of technetium-99 m-labeled tropanes as dopamine transporter-imaging agents. Meegalla S,Plossl K,Kung MP,et al. Journal of Medicinal Chemistry . 1997
- [8] Evaluation of striatal dopamine transporter function in rats by in vivo beta-123 I CIT pinhole SPECT. Scherfler C,Donnemiller E,Schocke M,et al. Neuroimage . 2002
- [9] The preclinical pharmacologic study of dopamine transporter imaging agent[99mTc]TRODAT-1. Fang P,Wu CY,Liu ZG,et al. Nuclear Medicine . 2000
- [10] [ 99m Tc]TRODAT-1: A novel technetium-99m complex as a dopamine transporter imaging agent[J] .  European Journal of Nuclear Medicine . 1997 (4)